|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Impetigo |
|
Infection, prophylaxis |
|
Infection, skin lesions |
| |
|
|
SIDE EFFECTS:
|
|
Cough |
|
respiratory disorder, including upper respiratory tract congestion |
|
Ear pain |
|
Headache |
|
Burning or stinging in the nose |
|
pharyngitis |
|
pruritus |
|
rhinitis |
|
taste perversion |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
Antibacterial, nasal-
Intranasal, approximately one half of the ointment from a single-use tube applied into each nostril two times a day (morning and evening) for five days. |
|
MAXIMUM ADULT DOSE:
|
|
Five days of twice-daily treatment .
|
|
PEDIATRIC DOSE:
|
|
Antibacterial, nasal-
Children up to 12 years of age: Safety has not been established .
Children 12 years of age and older: See Usual adult and adolescent dose . |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Antibacterial, nasal-
See Usual adult and adolescent dose . |
|
|
|
|